Artificial Intelligence Detects Cardiac Amyloidosis Before Clinical Diagnosis
Journal of Cardiac Failure · 2026-11 · 32 (11) · 2025-2028
DOI: 10.1016/j.cardfail.2026.06.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2026-11. Verfasst von Victoria Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine, University of California, Los Angeles, California; Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gordon and Betty Moore Foundation, Sarnoff Cardiovascular Research Foundation Inc, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Cardiac amyloidosis (CA) causes contractile dysfunction through the gradual deposition of amyloid fibrils within the myocardium. However, the diagnosis is often delayed given phenotypic mimickers.1 The approval of novel disease-modifying treatments offers an avenue to stabilize disease progression, with a greater clinical impact seen earlier in the course.2,3 Timely detection is imperative to connect patients with disease-specific management. Echocardiography is the most common form of cardiac imaging.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- David Geffen School of Medicine, University of California, Los Angeles, California; Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles, California.
- Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles, California.
- Division of Cardiology, Department of Medicine, Stanford University, Palo Alto, California.
- Division of Cardiology, Department of Medicine, Stanford University, Palo Alto, California; Kaiser Permanente Northern California Division of Research, Pleasanton, California; Kaiser Permanente San Francisco Medical Cen…
- Kaiser Permanente Northern California Division of Research, Pleasanton, California; Kaiser Permanente San Francisco Medical Center, San Francisco, California.
- Kaiser Permanente Santa Clara Medical Center, Santa Clara, California.
Förderung
- Gordon and Betty Moore Foundation
- Sarnoff Cardiovascular Research Foundation Inc
- National Heart Lung and Blood Institute
- American Heart Association Inc
Zitieren
APA
Yuan, V., Kalagara, S., Ieki, H., Bhatt, A. S., Ambrosy, A. P., Elezaby, A., Stern, L. K., Cheng, P. P., & Ouyang, D. (2026). Artificial Intelligence Detects Cardiac Amyloidosis Before Clinical Diagnosis. Journal of Cardiac Failure, 32(11), 2025-2028. https://doi.org/10.1016/j.cardfail.2026.06.030
Vancouver
Yuan V, Kalagara S, Ieki H, Bhatt AS, Ambrosy AP, Elezaby A, et al. Artificial Intelligence Detects Cardiac Amyloidosis Before Clinical Diagnosis. Journal of Cardiac Failure. 2026;32(11):2025-2028. doi:10.1016/j.cardfail.2026.06.030
BibTeX
@article{Yuan2026,
author = {Yuan, Victoria and Kalagara, Saisanjana and Ieki, Hirotaka and Bhatt, Ankeet S and Ambrosy, Andrew P and Elezaby, Aly and Stern, Lily K and Cheng, Paul P and Ouyang, David},
title = {Artificial Intelligence Detects Cardiac Amyloidosis Before Clinical Diagnosis},
journal = {Journal of Cardiac Failure},
year = {2026},
volume = {32},
number = {11},
pages = {2025--2028},
doi = {10.1016/j.cardfail.2026.06.030}
}
EUVIMED